AGP
PROK icon

Artia Global Partners’s ProKidney PROK Stock Holding History

Artia Global Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.23M Sell
1,806,939
-31,472
-2% -$66.8K 0.65% 30
2025
Q4 		$4.12M Buy
+1,838,411
New +$4.83M 0.58% 29

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Artia Global Partners's PROK Position: Q1 2026 in Review

Artia Global Partners reduced its ProKidney (PROK) stake by 1.7% in Q1 2026, selling an estimated $66.8K and leaving 1,806,939 shares worth $3.23M. The position accounts for 0.65% of the portfolio, ranked #30.

Artia Global Partners first reported a position in PROK in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.12M in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Artia Global Partners held 1,806,939 shares of ProKidney worth $3.23M as of Q1 2026.
  • Artia Global Partners sold 31,472 ProKidney shares in Q1 2026, an estimated $66.8K.
  • ProKidney made up 0.65% of Artia Global Partners's portfolio in Q1 2026, its #30 holding.
  • Artia Global Partners first reported a position in ProKidney in Q4 2025 and has held it in 2 quarters since.
  • Artia Global Partners's ProKidney position peaked at $4.12M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.